← Back to NON RARE IN EUROPE: Psoriatic arthritis

NON RARE IN EUROPE: Psoriatic arthritis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Apr 2026A Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. — PHASE2

TrialNOT YET RECRUITING
Dec 2025A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

UCB Biopharma SRL — PHASE1

TrialRECRUITING
Jan 2025A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

Second Affiliated Hospital, School of Medicine, Zhejiang University

TrialNOT YET RECRUITING
Jan 2025Modifying PEST for Psoriatic Arthritis Screening

Novartis Pharmaceuticals — NA

TrialRECRUITING
Jan 2025Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information

Shanghai Yueyang Integrated Medicine Hospital

TrialNOT YET RECRUITING
Feb 2024Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

Hansoh BioMedical R&D Company — PHASE2

TrialRECRUITING
Jan 2024Mat Pilates Exercise Program in Patients With Axial Psoriatic Arthritis

Izmir Katip Celebi University — NA

TrialENROLLING BY INVITATION
Jun 2023Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis

Ankara City Hospital Bilkent

TrialRECRUITING
Jan 2023Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity

Cairo University

TrialRECRUITING
Jul 2021A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Bristol-Myers Squibb — PHASE3

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for NON RARE IN EUROPE: Psoriatic arthritis.
Check the disease page for updates →

Clinical Trial Landscape

11 active trials
2Phase 3
1Phase 2
1Phase 1
2N/A
5Unknown
11Total recruiting
Search clinical trials for NON RARE IN EUROPE: Psoriatic arthritis

Recent News & Research

No recent news articles indexed yet for NON RARE IN EUROPE: Psoriatic arthritis.
Search PubMed for NON RARE IN EUROPE: Psoriatic arthritis

Browse all NON RARE IN EUROPE: Psoriatic arthritis news →

Specialist Network

No specialists currently listed for NON RARE IN EUROPE: Psoriatic arthritis.

View all NON RARE IN EUROPE: Psoriatic arthritis specialists →

Quick Actions